重症监护病房白念珠菌耐药性8年变化趋势

中国真菌学杂志　 2012, Vol. 7 　Issue (3): 150-152,169.

重症监护病房白念珠菌耐药性8年变化趋势

居学丰¹, 张伟², 吴晓¹, 单红卫², 管军²

1. 上海市嘉定区中心医院急诊科,上海 201800;
2. 上海长征医院急救科,上海 200003

收稿日期:2012-02-14 出版日期:2012-06-28 发布日期:2012-06-28
通讯作者: 管军,E-mail:drguanjun@hotmail.com E-mail:drguanjun@hotmail.com
作者简介:居学丰,男 (汉族),学士,主治医师.E-mail:xiaowei110@xjtu.edu.cn;
张伟,男 (汉族),学士,住院医师.E-mail:zhangwei_8@sina.com

Trend of drug resistance in clinical Candida albicans isolates from intensive care unit in Changzheng Hospital,2002-2009

JU Xu-feng¹, ZHANG Wei², WU Xiao¹, SHAN Hong-wei², GUAN Jun²

1. Emergency Department,Central Hospital of Jiading District,Shanghai,201800,China;
2. Critical Care and Emergency Department,Shanghai Changzheng Hospital,Shanghai,200003,China

Received:2012-02-14 Online:2012-06-28 Published:2012-06-28

摘要/Abstract

摘要： 目的调查上海长征医院重症监护室 (ICU)近8 a中临床分离白念珠菌的耐药性变化,为临床治疗提供参考。方法上海长征医院ICU 2002~2009年从414例患者中首次分离出414株白念珠菌,对其中277株进行药敏试验。采用Cox-Stuart趋势检验回顾性分析临床分离真菌中白念珠菌所占比例变化趋势和白念珠菌对常用抗真菌药物耐药率的变化趋势。结果 2002~2009年间,上海长征医院ICU白念珠菌分离株数从2002年的34株增加至2009年的92株,但白念珠菌占总真菌分离株数的百分比维持在34.6%~55.7%,P=0.03。白念珠菌对于5-氟胞嘧啶和两性霉素B平均耐药率分别为4.0%和0.7%,对其他常用抗真菌药的耐药率依次为咪康唑47.0%、酮康唑10.8%、伊曲康唑19.9%、特比萘芬42.6%、氟康唑14.6%及伏立康唑13.0%。白念珠菌对5-氟胞嘧啶和两性霉素B和伊曲康唑耐药率的8年变化无统计学差异。结论上海长征医院ICU近8 a来白念珠菌仍然为临床较为常见的真菌分离株,但白念珠菌占总分离株数的百分比有逐渐减少的趋势。白念珠菌对常用抗真菌药物耐药性均无明显变化趋势。

关键词: 重症监护病房, 白念珠菌, 药物耐药性, 趋势分析

Abstract: Objective To investigate an eight-year resistance change of clinically isolated Candida albicans strains in intensive care unit (ICU) in our hospital and to provide a reference for clinical diagnosis and treatment.Methods Four hundred and fourteen Candida albicans strains were isolated from 414 cases in ICU during 2002-2009. Among those isolates, 277 strains were performed sensitivity tests. Cox-Stuart trend test was used to analyze the change of Candida albicans proportion in whole isolated fungi and their resistance to commonly used antifungal angents.Results The Candida albicans isolates increased from 34 in 2002 to 92 in 2009, while their proportions in whole isolated fungi ranged from 34.6% to 55.7% (P=0.03). Average resistance rates of Candida albicans to antifungal angents were 5-fluorocytosine 4.0%, amphotericin B 0.7%, miconazole 47.0%, ketoconazole 10.8%, itraconazole 19.9%, terbinafine 42.6%, fluorocytosine 14.6% and voriconazole 13.0%, respectively. No significant changes of Candida albicans resistance to 5-fluorocytosine, amphotericin B and itraconazole in 8 years were detected (P=0.06,P=0.06,P=0.31 respectively).Conclusions The recent eight-year data shows Candida albicans still remains to be the commonest clinical fungal isolate in ICU in Changzheng Hospital,though its proportion in whole fungal isolates being in trend of decrease, and its resistant rate to commonly used antifungal agents having not changed significantly.

Key words: intensive care unit, Candida albicans, drug resistance, trend analysis

中图分类号:

R 519.3

居学丰, 张伟, 吴晓, 单红卫, 管军. 重症监护病房白念珠菌耐药性8年变化趋势[J]. 中国真菌学杂志, 2012, 7(3): 150-152,169.

JU Xu-feng, ZHANG Wei, WU Xiao, SHAN Hong-wei, GUAN Jun. Trend of drug resistance in clinical Candida albicans isolates from intensive care unit in Changzheng Hospital,2002-2009[J]. Chinese Journal of Mycology, 2012, 7(3): 150-152,169.

参考文献

[1] Hope W, Morton A, Elsen DP. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use[J].Hosp Infect,2002,5(10):56-65.
[2] Bassetti M,Ansaldi F,Nicolini L,et al.Incidence of candidaemia and relationship with fluconazole use in an intensive care unit[J] . J Antimicrob Chemother,2009,64(3):625-629.
[3] 丁亚兴,胡东生. 单向等级数据的趋势检验[J].郑州大学学报,2007,7(42):756-758.
[4] Rubio PM,Sevilla J,Conzalez.Vicent M,et al.Increasing incidence of invsive aspergillosis in pediatric hematology oncology patients over the last decade:a retrospective single centre study [J]. J Pediatr Hematol Oncol,2009,31(9):642-646.
[5] 刘雪燕,徐勇,文舜康,等. 重症监护病房医院真菌感染危险因素分析[J]. 中华医院感染学杂志,2005,15(1):31-32.
[6] 冯文莉,杨静,奚志琴,等. 3年间医院内侵袭性真菌感染的病原菌分布及临床分析[J].中华医院感染学杂志, 2006,16(12):1861-1863.
[7] Haynes K.Virulence in Candida species [J]. Trends Microbiol,2001,9(12):591-596.
[8] 吴建华,沈洁,王英,等. 院内患者深部真菌感染的流行病学调查[J]. 中国真菌学杂志, 2006, 1(6) : 337-339.
[9] 陈莉文,席玉胜,孟猛,等. 氟康唑对院内深部真菌感染的预防观察与分析[J]. 中国现代医学杂志,2008,18(7):1030-1033.[ZK)]
[10] [ZK(#]刘永碧,马厚勋,曾凡荣,等.深部念珠菌感染280例临床分析[J].中华医院感染学杂志, 1998, 8(1):31-36.
[11] 戴丽. 真菌性败血症16 例临床分析[J]. 中国医师进修杂志, 2007,30(10):64-67.
[12] 王海生. 抗感染药物合理应用[M].北京:人民卫生出版社, 2002,345-360.
[13] 王山梅,孙长义. 深部真菌感染阳性血培养的结果分析[J]. 中原医刊, 2007,34(23):94 -105.

[1]	刘丹, 邢丽枝, 杨心茹, 罗伟, 何荣霞. 唑类药物治疗外阴阴道假丝酵母菌病研究进展[J]. 中国真菌学杂志, 2020, 15(5): 318-320.
[2]	马玉帛, 张逸, 黄晨, 王晓雯, 李若瑜. 自然杀伤细胞在真菌感染免疫的研究进展[J]. 中国真菌学杂志, 2020, 15(3): 175-178.
[3]	邱熙然, 陈思敏, 侯炜彤, 张玉, 郭诗雨, 姜远英, 安毛毛. 白念珠菌侵袭宿主毒力因子研究进展[J]. 中国真菌学杂志, 2020, 15(3): 183-188.
[4]	张静云, 彭靖雯, 王琼, 高盈, 陈万鑫, 沈永年, Li Dong-mei, 佘晓东, 刘维达. 表皮生长因子受体在阴道念珠菌病发病过程中的作用初探[J]. 中国真菌学杂志, 2020, 15(2): 65-71.
[5]	刘光荣, 翟春涛, 金敏蓉, 李成亮. 天然抗菌剂对5种致病菌的抑制作用研究[J]. 中国真菌学杂志, 2020, 15(2): 88-92.
[6]	谭静文, 徐红, 宋金凤, 高志琴, 杨虹, 杨连娟, 温海. 聚六亚甲基双胍体外抗真菌作用研究[J]. 中国真菌学杂志, 2020, 15(2): 93-96.
[7]	张静云, 佘晓东, 刘维达. 白念珠菌糖代谢与毒力[J]. 中国真菌学杂志, 2020, 15(1): 61-64.
[8]	赵晓琴, 冯文莉. 转录因子在白念珠菌生物膜形成过程中的调控机制[J]. 中国真菌学杂志, 2019, 14(6): 381-384.
[9]	王钰婷, 王玉柱, 刘锦燕, 孟玲宁, 李卫华, 项明洁. 酵母相和菌丝相白念珠菌感染阴道上皮细胞免疫反应的比较[J]. 中国真菌学杂志, 2019, 14(4): 193-199.
[10]	蔡晴, 杨连娟, 高志琴, 任弘瑾, 杨虹, 谭静文. 罗米地辛对氟康唑体外抗白念珠菌影响的研究[J]. 中国真菌学杂志, 2019, 14(4): 200-203,216.
[11]	葛力瑜, 梁官钊, 刘维达. 抗黏膜白念珠菌感染的固有免疫研究进展[J]. 中国真菌学杂志, 2019, 14(4): 249-252.
[12]	姬名硕, 王晓东, 帕丽达·阿布利孜. NLRP3炎症小体在真菌感染中的作用机制研究进展[J]. 中国真菌学杂志, 2019, 14(4): 253-256.
[13]	施高翔, 姜晶晶, 汪云霞, 赵婷, 邵菁, 汪天明, 汪长中. 苦参-蛇床子药对提取物对白念珠菌VVC临床株的抑制作用研究[J]. 中国真菌学杂志, 2019, 14(3): 147-153.
[14]	沈煜宸, 曹毅, 陶茂灿. 白念珠菌生物膜耐药机制及中药治疗的研究进展[J]. 中国真菌学杂志, 2019, 14(3): 176-179.
[15]	胡婵, 曹智, 吴煜昊, 张国龙, 王秀丽. 白念珠菌氧化应激机制的研究进展[J]. 中国真菌学杂志, 2019, 14(3): 189-192.